Immunologic Research

, Volume 65, Issue 1, pp 395–401 | Cite as

Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall

  • Caroline Maris Takatu
  • Antonio Pedro Ribeiro Heringer
  • Valéria Aoki
  • Neusa Yuriko Sakai Valente
  • Paula Cristina de Faria Sanchez
  • Jozélio Freire de Carvalho
  • Paulo Ricardo Criado
Mechanism in Autoimmunity

Abstract

This is the largest direct immunofluorescence (DIF) analysis of patients with histology-proven cutaneous leukocytoclastic vasculitis (LCV). To establish the correlation of deposition of immune complexes at the blood vessel walls with underlying causes and prognosis of LCV, we performed a retrospective study from January 2007 to December 2014. The patients are followed at the Department of Dermatology, Hospital Das Clínicas da Faculdade de Medicina da Universidade de São Paulo, a tertiary hospital at São Paulo, Brazil. We reviewed the data of 282 biopsy-proven LCV cases with DIF performed. For the statistical analysis, we included only patients with positive DIF exclusively in vessel walls (235/282 patients). We planned to find a correlation between the DIF profiles of LCV patients and the epidemiology data, underlying causes and prognosis. Ages ranged from five to 87 years old (yo), median age of 45 and 191/282 (67.73 %) were female individuals. DIF analysis showed positivity in 70.21 % of the samples, and C3 was the most frequent immunoreactant. Immunoglobulin A (IgA) deposition at the blood vessel wall was related to age and absence of autoimmune/inflammatory diseases. Immunoglobulin M (IgM) deposition at the blood vessel wall was related to females, autoimmune/inflammatory disorders, C3 and C4 consumption and antinuclear antibody and anti-SSA/anti-SSB positivity. Immunoglobulin G (IgG) deposition at the blood vessel wall was associated with age and positive ANCA; finally, C3 deposition at the blood vessel wall was associated with hematuria and renal involvement. Systemic involvement was present in 12.5 % cases of LCV patients. C3 deposits, the most frequent finding of this study, were related to renal involvement; IgA deposits to absence of autoimmune or inflammatory diseases; IgM deposition to the presence of autoimmune or inflammatory diseases and IgG deposits were associated with positive ANCA. DIF seems to be an important method to establish the prognosis and underlying etiology of LCV. Characterization of the immune complex at the blood vessel wall by DIF is relevant to determine underlying conditions related to LCV.

Keywords

Cutaneous vasculitis Cutaneous leukocytoclastic vasculitis Cutaneous small vessel vasculitis Direct immunofluorescence 

Notes

Acknowledgments

We are indebted to Daniel Silvestre—LIM01 University of São Paulo Medical School, Brazil—for the help with the statistical analysis.

Author Contributions

Dr(s) Heringer and Takatu had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Heringer, Takatu, Criado, Aoki, Valente, and Sanchez contributed to study concept and design. Heringer, Takatu, and Sanchez contributed to acquisition, analysis, and interpretation of data, and drafting of the manuscript. Aoki, Criado, Valente, and Carvalho critically revised the manuscript for important intellectual content. Daniel Silvestre performed the statistical analysis. No funding was obtained. Aoki and Criado provided administrative, technical, or material support. Aoki, Valente, and Criado supervised the study.

Compliance with Ethical Standards

Conflict of interest

None.

References

  1. 1.
    Lotti T, Ghersetich I, Comacchi C, Jorizzo JL. Cutaneous small-vessel vasculitis. J Am Acad Dermatol. 1998;39(5 Pt 1):667–87.CrossRefPubMedGoogle Scholar
  2. 2.
    Tosca N, Stratigos JD. Possible pathogenetic mechanisms in allergic cutaneous vasculitis. Int J Dermatol. 1988;27(5):291–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Minz RW, Chhabra S, Singh S, Radotra BD, Kumar B. Direct immunofluorescence of skin biopsy: perspective of an immunopathologist. Indian J Dermatol Venereol Leprol. 2010;76(2):150–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Takeuchi S, Soma Y, Kawakami T. IgM in lesional skin of adults with Henoch-Schönlein purpura is an indication of renal involvement. J Am Acad Dermatol. 2010;63(6):1026–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Barnadas MA, Pérez E, Gich I, et al. Diagnostic, prognostic and pathogenic value of the direct immunofluorescence test in cutaneous leukocytoclastic vasculitis. Int J Dermatol. 2004;43(1):19–26.CrossRefPubMedGoogle Scholar
  6. 6.
    Alalwani M, Billings SD, Gota CE. Clinical significance of immunoglobulin deposition in leukocytoclastic vasculitis: a 5-year retrospective study of 88 patients at cleveland clinic. Am J Dermatopathol. 2014;36(9):723–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Zurada JM, Ward KM, Grossman ME. Henoch-Schönlein purpura associated with malignancy in adults. J Am Acad Dermatol. 2006;55(5 Suppl):S65–70.CrossRefPubMedGoogle Scholar
  8. 8.
    Gibson LE. Cutaneous vasculitis update. Dermatol Clin. 2001;19(4):603–15.CrossRefPubMedGoogle Scholar
  9. 9.
    Russell JP, Gibson LE. Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment. Int J Dermatol. 2006;45(1):3–13.CrossRefPubMedGoogle Scholar
  10. 10.
    Sais G, Vidaller A, Jucglà A, Servitje O, Condom E, Peyri J. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol. 1998;134(3):309–15.CrossRefPubMedGoogle Scholar
  11. 11.
    Linskey KR, Kroshinsky D, Mihm MC, Hoang MP. Immunoglobulin-A–associated small-vessel vasculitis: a 10-year experience at the Massachusetts General Hospital. J Am Acad Dermatol. 2012;66(5):813–22.CrossRefPubMedGoogle Scholar
  12. 12.
    Belli AA, Dervis E. The correlation between cutaneous IgM deposition and renal involvement in adult patients with Henoch–Schönlein purpura. Eur J Dermatol. 2014;24(1):81–4.PubMedGoogle Scholar
  13. 13.
    Mackel SE, Jordon RE. Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Arch Dermatol. 1982;118(5):296–301.CrossRefPubMedGoogle Scholar
  14. 14.
    Sanchez NP, Van Hale HM, Su WP. Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases. Arch Dermatol. 1985;121(2):220–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Merrill J, Lahita RG. Henoch-Schönlein purpura remitting in pregnancy and during sex steroid therapy. Br J Rheumatol. 1994;33(6):586–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Joseph G, Holtman JS, Kosfeld RE, Blodgett WA, Liu YK. Pregnancy in Henoch-Schönlein purpura. Am J Obstet Gynecol. 1987;157(4 Pt 1):911–2.CrossRefPubMedGoogle Scholar
  17. 17.
    Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet. 1992;339(8788):280–2.CrossRefPubMedGoogle Scholar
  18. 18.
    Koizumi M, Hagino D, Fukuyama C, et al. Schönlein-Henoch purpura during pregnancy: case report and review of the literature. J Obstet Gynaecol Res. 2004;30(1):37–41.CrossRefPubMedGoogle Scholar
  19. 19.
    Borahay MA, Kelly BC, Harirah HM. Systemic lupus erythematosus presenting with leukocytoclastic vasculitis and seizure during pregnancy. Am J Perinatol. 2009;26(6):431–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Tomizawa K, Sato-Matsumura KC, Kajii N. The coexistence of cutaneous vasculitis and thrombosis in childhood-onset systemic lupus erythematosus with antiphospholipid antibodies. Br J Dermatol. 2003;149(2):439–41.CrossRefPubMedGoogle Scholar
  21. 21.
    Sánchez-Pérez J, Peñas PF, Ríos-Buceta L, Fernández-Herrera J, Fraga J, García-Díez A. Leukocytoclastic vasculitis in subacute cutaneous lupus erythematosus: clinicopathologic study of three cases and review of the literature. Dermatology. 1996;193(3):230–5.CrossRefPubMedGoogle Scholar
  22. 22.
    Yasue T. Livedoid vasculitis and central nervous system involvement in systemic lupus erythematosus. Arch Dermatol. 1986;122(1):66–70.CrossRefPubMedGoogle Scholar
  23. 23.
    Oien RF, Håkansson A, Hansen BU. Leg ulcers in patients with rheumatoid arthritis—a prospective study of aetiology, wound healing and pain reduction after pinch grafting. Rheumatology (Oxford). 2001;40(7):816–20.CrossRefGoogle Scholar
  24. 24.
    Westedt ML, Meijer CJ, Vermeer BJ, Cats A, de Vries E. Rheumatoid arthritis—the clinical significance of histo- and immunopathological abnormalities in normal skin. J Rheumatol. 1984;11(4):448–53.PubMedGoogle Scholar
  25. 25.
    Carlson JA, Chen KR. Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am J Dermatopathol. 2007;29(1):32–43.CrossRefPubMedGoogle Scholar
  26. 26.
    Brons RH, de Jong MC, de Boer NK, Stegeman CA, Kallenberg CG, Tervaert JW. Detection of immune deposits in skin lesions of patients with Wegener’’ granulomatosis. Ann Rheum Dis. 2001;60(12):1097–102.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Sánchez-Guerrero J, Gutiérrez-Ureña S, Vidaller A, Reyes E, Iglesias A, Alarcón-Segovia D. Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J Rheumatol. 1990;17(11):1458–62.PubMedGoogle Scholar
  28. 28.
    García-Porrúa C, González-Gay MA. Cutaneous vasculitis as a paraneoplastic syndrome in adults. Arthritis Rheum. 1998;41(6):1133–5.CrossRefPubMedGoogle Scholar
  29. 29.
    Fain O, Hamidou M, Cacoub P, et al. Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum. 2007;57(8):1473–80.CrossRefPubMedGoogle Scholar
  30. 30.
    Pertuiset E, Lioté F, Launay-Russ E, Kemiche F, Cerf-Payrastre I, Chesneau AM. Adult Henoch-Schönlein purpura associated with malignancy. Semin Arthritis Rheum. 2000;29(6):360–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Podjasek JO, Wetter DA, Pittelkow MR, Wada DA. Henoch-Schönlein purpura associated with solid-organ malignancies: three case reports and a literature review. Acta Derm Venereol. 2012;92(4):388–92.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Caroline Maris Takatu
    • 1
  • Antonio Pedro Ribeiro Heringer
    • 1
  • Valéria Aoki
    • 1
  • Neusa Yuriko Sakai Valente
    • 1
  • Paula Cristina de Faria Sanchez
    • 1
  • Jozélio Freire de Carvalho
    • 2
  • Paulo Ricardo Criado
    • 1
  1. 1.Department of Dermatology, Hospital das ClínicasUniversity of São Paulo Medical SchoolSão PauloBrazil
  2. 2.Health Science InstituteFederal University of BahiaSalvadorBrazil

Personalised recommendations